Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

55 Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ et al.
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an
international inception cohort study. Arthritis Rheum 2007; 56: 265–273.
56 Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, Combes a, Tieulié N et al.
Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four
new cases and review of the literature. Lupus 2008; 17: 139–47.
57 Brey RL, Holliday SL, Saklad a R, Navarrete MG, Hermosillo-Romo D, Stallworth CL et
al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.
Neurology 2002; 58: 1214–1220.
58 Ruiz-Irastorza G, Garmendia M, Villar I, Egurbide M-V, Aguirre C. Pulmonary
hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic
strategy. Autoimmun Rev 2013; 12: 410–415.
59 Cerovec M, Ani B, Padjen I, ikeš N. Prevalence of the American College of
Rheumatology classification criteria in a group of 162 systemic lupus erythematosus
patients from Croatia. Croat Med J 2012; 53: 149–154.
60 Cervera R, Piette J, Font J, Khamashta MA, Shoenfeld Y, Camps T et al.
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of
disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019–1027.
61 Alarcón-Segovia D, Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary
classification criteria for the antiphospholipid síndrome within systemic lupus
erythematosus. Semin Arthritis Rheum 1992; 21: 275–86.
62 Vianna J, Khamashta M, Ordi-Ros J. Comparison of the primary and secondary
antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med
1994; 96: 3–9.
63 To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in
systemic lupus erythematosus? Arthritis Rheum 2005; 52: 4003–4010.
64 Vila LM, Molina MJ, Mayor a M, Peredo R a, Santaella ML, Vila S. Clinical and
prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus.
Lupus 2006; 15: 892–898.
65 Cervera R, Khamashta M, Font J, Sebastiani G, Gil A, Lavilla P et al. Systemic lupus
erythematosus: clinical and inmunological patterns of disease expression in a cohort of
1000 patients. The European Working Party on Systemic Lupus Erythematosus. Med
1992; 72: 113–124.
66 Rúa-Figueroa I, López-Longo F. Registro nacional de pacientes con lupus eritematoso
sistémico de la Sociedad Española de Reumatología: objetivos y metodología. Reumatol
Clínica 2014; 10: 17–24.
67 Ramal LM, López-Nevot M a, Sabio JM, Jáimez L, Paco L, Sánchez J et al. Systemic lupus
erythematosus in southern Spain: a comparative clinical and genetic study between
Caucasian and Gypsy patients. Lupus 2004; 13: 934–940.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 439